NRXPW — NRx Pharmaceuticals, Inc.
$0.0026-25.71%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for NRXPW in the TickerWise workspace.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Website: https://www.nrxpharma.com
Latest SEC filings for NRXPW
- 424B5
- 424B5
- 25-NSE
- SCHEDULE 13G/A
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.